Respiratory tract barrier dysfunction plays a critical role in the progression of viral-bacterial co-infections, particularly in the context of influenza virus and Streptococcus pneumoniae. A preceding viral infection can predispose the host to secondary bacterial pneumonia, increasing morbidity and mortality. This review focuses on the dysfunction of the respiratory barrier, which includes physical and secretory barriers as well as immune defense mechanisms, in the context of viral-bacterial synergy. Understanding how the respiratory tract responds to viral-bacterial co-infections can lead to the development of effective therapeutic strategies for preventing enhanced susceptibility to these pathogens. Viral infections, such as influenza, can impair mucociliary clearance and salivary barrier function, leading to increased bacterial colonization and dissemination into the lower respiratory tract. Neuraminidase activity from both viruses and bacteria can cleave sialic acids, exposing cryptic receptors that facilitate bacterial adherence and proliferation. Inflammatory responses can also upregulate receptors on infected cells, promoting bacterial dissemination. Additionally, injured or differentiating cells may provide additional receptors for bacterial adhesion. The interaction between oral bacteria and viral infections can further exacerbate respiratory infections. Oral bacteria, such as Porphyromonas gingivalis, can increase the expression of host receptors like PAFR, enhancing bacterial adhesion and invasion. The dysfunction of the epithelial barrier, including the loss of tight junctions and disruption of junctional proteins, can also contribute to increased susceptibility to secondary bacterial infections. Viral infections can also impair immune responses, reducing the production of cytokines and chemokines necessary for neutrophil recruitment and activation. This can suppress bacterial clearance and increase the risk of secondary infections. The interplay between viral and bacterial factors, including the role of host receptors like GP96, is crucial in the pathogenesis of co-infections. Overall, the complex mechanisms underlying viral-bacterial co-infections highlight the importance of maintaining respiratory tract barrier function and addressing risk factors such as poor oral hygiene and chronic diseases. Further research is needed to develop effective therapeutic strategies for preventing and managing these infections.Respiratory tract barrier dysfunction plays a critical role in the progression of viral-bacterial co-infections, particularly in the context of influenza virus and Streptococcus pneumoniae. A preceding viral infection can predispose the host to secondary bacterial pneumonia, increasing morbidity and mortality. This review focuses on the dysfunction of the respiratory barrier, which includes physical and secretory barriers as well as immune defense mechanisms, in the context of viral-bacterial synergy. Understanding how the respiratory tract responds to viral-bacterial co-infections can lead to the development of effective therapeutic strategies for preventing enhanced susceptibility to these pathogens. Viral infections, such as influenza, can impair mucociliary clearance and salivary barrier function, leading to increased bacterial colonization and dissemination into the lower respiratory tract. Neuraminidase activity from both viruses and bacteria can cleave sialic acids, exposing cryptic receptors that facilitate bacterial adherence and proliferation. Inflammatory responses can also upregulate receptors on infected cells, promoting bacterial dissemination. Additionally, injured or differentiating cells may provide additional receptors for bacterial adhesion. The interaction between oral bacteria and viral infections can further exacerbate respiratory infections. Oral bacteria, such as Porphyromonas gingivalis, can increase the expression of host receptors like PAFR, enhancing bacterial adhesion and invasion. The dysfunction of the epithelial barrier, including the loss of tight junctions and disruption of junctional proteins, can also contribute to increased susceptibility to secondary bacterial infections. Viral infections can also impair immune responses, reducing the production of cytokines and chemokines necessary for neutrophil recruitment and activation. This can suppress bacterial clearance and increase the risk of secondary infections. The interplay between viral and bacterial factors, including the role of host receptors like GP96, is crucial in the pathogenesis of co-infections. Overall, the complex mechanisms underlying viral-bacterial co-infections highlight the importance of maintaining respiratory tract barrier function and addressing risk factors such as poor oral hygiene and chronic diseases. Further research is needed to develop effective therapeutic strategies for preventing and managing these infections.